Literature DB >> 1570874

Decreasing medication use in a nursing-home patient-care unit.

P V Laucka1, N B Hoffman.   

Abstract

The effect of a computerized drug regimen review and expanded clinical pharmacy services on medication use in a nursing-home care unit was studied. A full-time pharmacist assigned to the 120-bed nursing-home care unit of a Veterans Affairs medical center initiated a program to reduce medication use to an average of 6.1 medications per patient. The pharmacist used a monthly, computer-generated drug regimen review report to document the number of medications per patient and recommend decreases in medication use to physicians. Initiation of a standing-order policy, whereby nurses can initiate the use of specific medications, helped to reduce the number of as-needed (p.r.n.) orders and also decreased use of these medications. Within one year, the number of p.r.n. and scheduled medications used per patient was reduced from 7.20 to 5.34. Use of routinely scheduled medications was reduced by about 30%. Based on an average cost of medications administered ($0.24/dose), we calculated a cost savings of about $27,400. By reviewing patients' drug regimens, establishing a standing-order policy, and targeting scheduled medications for discontinuation, a pharmacist reduced medication use in a nursing home.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1570874

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  3 in total

1.  Drug use in Swedish nursing homes.

Authors:  C B Claesson; I K Schmidt
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 2.  Causes and problems of nonresponse or poor response to drugs.

Authors:  P Salvà Lacombe; J A García Vicente; J Costa Pagès; P Lucio Morselli
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 3.  Pharmacist services in nursing homes: A systematic review and meta-analysis.

Authors:  Shaun Wen Huey Lee; Vivienne Sook Li Mak; Yee Woon Tang
Journal:  Br J Clin Pharmacol       Date:  2019-11-03       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.